The Philadelphia-based diversified chemical company serves agricultural, consumer and industrial markets with solutions, applications and products.
"After considering an initial recalibration of expectations, we believe FMC has fallen to a level where it is a compelling long term buying opportunity," the firm said in an analyst note.
Credit Suisse remains concerned about global farmer profitability, channel and on-site inventories and credit availability in emerging markets, especially in Brazil.
However, the elimination of third party sales, long term growth opportunities in Europe and Latin America, greater product breadth, further country expansion, broadening local product portfolios and cost reductions will ultimately supersede 2016 FX and inventory, the firm noted.
Shares of FMC are rising by 2.11% to $35.85 at the start of trading on Friday.
Separately, TheStreet Ratings Team has a "sell" rating with a score of D+ on FMC.
This is driven by some concerns, which the team believes should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks it covers.
The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, feeble growth in its earnings per share, unimpressive growth in net income, disappointing return on equity and poor profit margins.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: FMC